Therefore, metabolic regulatory molecules such as insulin (Nelson and Alkon 2005), glucagon-like peptide 1 (Chen et al. 2014, 2019) and fibroblast growth factor 21(FGF21) (Chen et al. 2019) may represent potential pharmacotherapies for neurodegenerative diseases. Here, FGF21 is linked to neurodegenerative disease.